BioNanoLab is focused on the hypothesis that the current understanding on the potential health risks of advanced bio- and nanomaterials (BNMs) needs to expand beyond traditional risk assessment that primarily relies on animal-testing, to include faster and cheaper non-animal alternatives that can provide mechanistic insights about the particular characteristics of BNMs responsible for adverse health effects, hence, we bring together multiple disciplines including computer science to develop risk reduction strategies for BNMs that are commonly used in medical applications. This inter-disciplinary concept will enable a more productive approach to integrating safety into the design process of manufactured BNMs, and will contribute to the safe and sustainable development of bio/nano-technologies.